Dupilumab with Concomitant Topical Corticosteroids in Atopic Dermatitis Patients who are Inadequately Controlled with or Medically Inadvisable for Cyclosporine A: a Phase 3 Clinical Trial (LIBERTY AD CAFE). SKIN The Journal of Cutaneous Medicine, [S. l.], v. 1, n. 3.1, p. s37, 2017. DOI: 10.25251/skin.1.supp.36. Disponível em: https://skin.dermsquared.com/skin/article/view/200. Acesso em: 19 apr. 2025.